Taiwan FDA registration 40def96752f576b3cf8c2e04efd78c68

"Zeiss" Toby astigmatism corrects hydrophilic posterior chamber intraocular lenses

TW: “蔡司” 托比散光矯正親水性後房人工水晶體
Taiwan flagTaiwan·Risk Class 3·CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS·Registered Mar 23, 2023 – Mar 23, 2028Active
Registration details
Analysis ID
40def96752f576b3cf8c2e04efd78c68
Customs Code
DHA05603633404
Company information
Manufacturer Country
France;;Germany
Authorized Representative
Carl Zeiss Co., Ltd. Taipei Branch
Product details
Intended Use
Details are as detailed as approved Chinese instructions
Product Type (Level 1)
M Ophthalmology
Product Type (Level 2)
M.3600 Artificial Crystal
Import Information
Contract manufacturing;; input
Dates and status
Registration Date
Mar 23, 2023
Expiry Date
Mar 23, 2028
Companies making similar products

Top companies providing products similar to ""Zeiss" Toby astigmatism corrects hydrophilic posterior chamber intraocular lenses"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for "Zeiss" Toby astigmatism corrects hydrophilic posterior chamber intraocular lenses in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 40def96752f576b3cf8c2e04efd78c68 and manufactured by CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec SAS. The authorized representative in Taiwan is Carl Zeiss Co., Ltd. Taipei Branch.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including CARL ZEISS MEDITEC AG;; Carl Zeiss Meditec AG, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors2 Recent Registrations